Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC TrendingStockAlerts · Sep 7, 2025
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology TrendingStockAlerts · Sep 6, 2025
Nektar Therapeutics to Participate in Two Investor Conferences in September TrendingStockAlerts · Sep 5, 2025
Dr. Sunil Chandran Rejoins Amyris as Chief Technology Officer to Meet Growing Customer Demand for Innovative and Renewable Biological Chemistry TrendingStockAlerts · Sep 4, 2025
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting TrendingStockAlerts · Sep 3, 2025
CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry TrendingStockAlerts · Sep 2, 2025
US FDA approves Leqembi® IQKLIK ™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's disease TrendingStockAlerts · Sep 1, 2025
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress TrendingStockAlerts · Aug 30, 2025
Resolution Therapeutics to host virtual R&D webinar alongside world leading clinical hepatologists Prof. Jonathan Fallowfield and Dr. Elliot Tapper TrendingStockAlerts · Aug 28, 2025
BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties TrendingStockAlerts · Aug 27, 2025
